
Gene therapy is emerging as a promising treatment for inborn errors of immunity (IEI), particularly for severe combined immunodeficiency (SCID), by correcting genetic defects in patients' cells. Advances in gene insertion and editing technologies have led to successful clinical trials and are currently being explored for other IEIs like chronic granulomatous disease and Wiskott-Aldrich syndrome.
Like
Save
Share